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Background: The aim of this research was to study the levels of 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) in
tumour tissue samples of colorectal carcinoma based upon immunohistochemical detection and compare those
results with patients’ outcome.
Methods: Tumour blocks of patients surgically treated for colorectal cancer were evaluated by 8-oxodG
immunohistochemical staining. The expression was analysed in 500 tumour cells. The percentage of positive cells,
as well as staining intensity, was recorded, and Allred score was calculated. For each patient, data of age, gender,
tumour size and location, margin status, histologic grade, tumour stage, lymph node status, vascular invasion,
overall survival, and therapy protocols were collected. Tumour grade was divided into two groups as low and high
grade.
Results: In this study, 146 consecutive patients with primary colorectal carcinoma were included. All data were
available for 138 patients, and they were included in this research. There were 83 male and 55 female patients;
the median age was 64 years (range 35–87 years). The results showed shorter 5- and 10-year survival in
patients with 8-oxodG positive tumour cells (5-year survival, n = 138, Mantel–Cox, chi-square 4.116, degree of
freedom (df) = 1, p < 0.05; 10-year survival, n = 134, Mantel–Cox, chi-square 4.374, df = 1, p < 0.05). The results
showed a positive correlation between Allred score and high tumour grade (two-tailed Spearman’s ρ 0.184;
p < 0.05), as well as with non-polypoid tumour growth (two-tailed Spearman’s ρ 0.198; p < 0.05). There was no
significant difference of 8-oxodG expression related to age, sex, blood group, size and tumour site, distance
from the edge of the resected tumour margin, lymph nodes involvement, and vascular invasion.
Conclusions: In this study, the positive correlation between 8-oxodG presence in the tumour cells, worse
clinical outcome, higher tumour grade, and flat morphology was found.
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Colorectal cancer (CRC) originates from the colonic
mucosal epithelial cells and represents a genomic dis-
ease that is the result of the cumulative effect of exter-
nal and hereditary factors. Progression of the tumour
is due to the clonal cell expansion with a selective
growth advantage compared to surrounding epithelial
cells. It is well known that cells located at the bottom
of the crypt are more susceptible to oxidative damage
due to the presence of hydrogen peroxide, in relation
to the well-differentiated surface cells [1]. These cells
proliferate and often have a high metabolic index, and for
that reason, deoxyribonucleic acid (DNA) is exposed to
oxidative stress [2]. Abnormal accumulation of oxidative
radicals underlies the pathology of a myriad of diseases and
biological processes, such as ageing, the occurrence of neu-
rodegenerative diseases, diabetes, atherosclerosis, asthma,
cardiovascular disease, and various malignancies [3]. Since
8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) was dis-
covered in 1984, it is known in the literature as a marker of
the deoxyguanosine damage and has been investigated in
many studies as a potential marker of carcinogenesis [4].
From previous studies, it can be concluded that the
presence of 8-oxodG has mutagenic potential in the
modification of code in DNA replication, with conse-
quent induction of guanine/cytosine to thymine/aden-
ine (GC→TA) transversion mutation. Those lesions in
the absence of repair become mutagenic and can lead to
further accumulation of mutations and cancer [5, 6]. Most
of the mutations present in sporadic CRC are the result of
replacing the one base pair of DNA [7]. The presence of
8-oxodG in human DNA varies from 0.5 to 5 per 100,000
guanine bases and can induce damage to other bases of
DNA [8]. The mechanism by which the accumulation of
oxidative radicals contributes to pathological conditions
includes damage or oxidative modification of biomole-
cules such as nucleotides, lipids, and proteins [9]. In pa-
tients with sporadic CRC, higher levels of whole-blood
oxygen radical production during chemiluminescence
were observed compared to healthy controls, although
the difference was not found in patients with heredi-
tary non-polyposis colorectal cancer (HNPCC) and fa-
milial adenomatous polyposis (FAP) syndrome. These
findings suggest a potential role of oxygen free radical
occurrence in sporadic CRCs [10]. Elevated levels of
various markers of oxidative stress, such as 8-oxodG,
nitrous oxide, lipid and glutathione peroxidase, cata-
lase, and reduced levels of cytosine methylation in
DNA were found in patients with CRC [11]. Among
the techniques for determination of oxidative modifica-
tion of nucleotides, methods such as high-performance
liquid chromatography with the use of a mass spec-
trometer (HPLC-MS) and high-performance chroma-
tography with the use of an electrochemical detector orgas chromatography with mass spectrometer results
with quantified estimate. On the contrary, 8-oxodG
monoclonal antibody immunohistochemical staining is
a qualitative assessment, enabling analysis of the struc-
tural oxidative damage inside of the cell [12]. In this
study, 8-oxodG immunohistochemical presence in colo-
rectal carcinoma tumour cells was analysed, and results
were correlated with multiple patient parameters and
known CRC survival predicting factors.
The hypothesis of this study is higher levels of 8-oxo-
7,8-dihydro-2′-deoxyguanosine (8-oxodG) in tumour tis-
sue samples of colorectal carcinoma correlate with higher
tumour grade and worse survival.
Methods
Design
The study was a retrospective cohort between 1 January
1999 and 31 December 2014 at the Department of Surgery
University Hospital Center Zagreb, Croatia. The study
was approved by the Ethics Committee of the University
Hospital Center Zagreb and the Ethics Committee of the
Medical School Zagreb, Croatia.
Patients and sample
In this study, 138 tumour paraffin blocks were used from
138 eligible patients with primary colorectal carcinoma, out
of 146 consecutive patients surgically treated at our institu-
tion between 1 January 1999 and 31 December 2000,
excluding hereditary CRCs. During the surgery, presence of
any distant metastases was recorded. Data of age, gender,
location and size of tumour, tumour stage, histological
grade, lymph node status, vascular invasion, distance from
the nearest edge of resected margin, overall survival in
months, and therapy protocols were collected for 146
patients, resulting in left censoring applied to 8 patients
due to missing most of the data. The patients alive after 31
December 2014 were right censored at survival analysis.
The survival status of 134 patients was available for 15 years
of follow-up. According to histological tumour grade, the
patients were divided into two groups: low grade (well- and
moderately differentiated tumours) and high grade (poorly
differentiated tumours).
Immunohistochemistry
For diagnostic purposes after fixation, tumours were par-
affin embedded, cut, and stained with a standard method
(haematoxylin–eosin) for light microscope analysis. For
additional immunohistochemical staining, 4-μm cuts were
used. Primary antibody anti-8 hydroxyguanosine (N45.1,
ab48508, Abcam, USA) was used for specimen staining
using immunoperoxidase avidin–biotin method in an
automatic stainer (Autostainer, Dako, Denmark). Positive
control in immunohistochemical staining was epidermis
from hairless mouse stained with this antibody. Negative
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body. The antigen–antibody reaction was visualized by
3,3-diaminobenzidine tetrahydrochloride (DAB).
Evaluation of immunohistochemistry staining
The percentage of positive cells and staining intensity in a
total of 500 counted tumour cells per patient sample were
recorded. The intensity of staining was classified into four
grades as negative (no staining), weak, medium, and inten-
sive by observation under different microscopic magnifica-
tion (Fig. 1). Allred immunohistochemistry score was
calculated which is based on the percentage of cells that are
stained by immunohistochemistry (0 to 5) and the intensity
of that staining (0 to 3), resulting in a possible total score of
0–8 [13].
Statistical analysis
All analyses were performed using SPSS for Windows ver-
sion 22 (SPSS Inc, USA). The descriptive statistic was used.
Difference between the groups was assessed using inde-
pendent t test procedure and Pearson’s chi-square test
where applicable. Survival was analysed using Cox regres-
sion models and Kaplan–Meier curves with starting point
defined as the end of surgical treatment and end points de-
fined as mortality at 15 years of follow-up. The Spearman’s
test examined correlations and log-rank test examined stat-
istical differences. Significance was determined by a prob-
ability value <0.05, with all p values two-sided.
Results and discussion
Results
Patient data and tumour characteristics are shown in
Table 1, and flow diagram representing number ofFig. 1 Intensity of antibody anti-8 hydroxyguanosine (N45.1, ab48508, Abca
×200; b weak, ×400; c medium, ×200; and d intensive, ×200. Counterstaininindividuals at each stage of study is shown in Fig. 2.
The median age of 138 CRC patients included in this
study was 64 years (range 35–87 years). The studied
group comprises of 55 women and 83 men. The ma-
jority of the patients were in higher local tumour stage
(Dukes C in 46.7 % patients), and almost half of the
patients were in clinical stages III and IV by tumour
node metastasis (TNM) classification of malignant
tumours from Union for International Cancer Control
(UICC). Metastatic disease was found at the time of
diagnosis in 15.2 % of the patients. None of the pa-
tients received neoadjuvant chemoradiotherapy pre-
operatively. Data on postoperative chemoradiotherapy
is missing in 73 patients of 138 (52.9 %). Those pa-
tients were not excluded from the results analysis.
Overall survival and 8-oxodG expression did not differ
significantly compared to the type of chemoradiother-
apy applied postoperatively. There was no difference in
survival between the patients regarding circumferential
resection margin. There were data about 5- and 10-year
survival for 138 and 134 patients, respectively. The median
follow-up was 169 months, range 166.75–171.25 months.
During follow-up, 86 out of 134 patients died, 20 patients
died in the group with Allred score 0, and 66 patients died
in the group with positive Allred score. Negative correl-
ation was noted between 5-year survival and intensity
of 8-oxodG reaction in tumour cells (N = 138; ρ −0.191,
p < 0.05), percentage of positive tumour cells (N = 138;
ρ −0.151, p < 0.05), and Allred score (N = 138; ρ −0.157,
p < 0.05). Shorter 5- and 10-year survival was noticed in
the patients with 8-oxodG positive tumour cells (5-year
survival, n = 138, Mantel–Cox, chi-square 4.116, degree
of freedom (df ) = 1, p < 0.05; 10-year survival, n = 134,m, USA) staining is shown, classified into four grades as a negative,
g haematoxylin
Table 1 Clinical and tumour data of patients
Colorectal
cancer
Colorectal cancer Allred score
negative
Allred score positive p
value
(n = 138) (n = 134) (n = 40) (n = 98)
Gender 0.087c
Females 55 (39.9 %) 55 (41 %) 20 (50 %) 35 (35.7 %)
Males 83 (60.1 %) 79 (59 %) 20 (50 %) 63 (64.3 %)
Average age (year) 64 SD ±10 64 SD ±10 65 SD ±10 64 SD ±10 0.662d
Dukes pathology 0.819c
A 30 (21.7 %) 29 (21.6 %) 10 (25 %) 20 (20.4 %)
B 45 (32.6 %) 43 (32.1 %) 13 (32.5 %) 32 (32.7 %)
C 63 (45.7 %) 62 (46.3 %) 17 (42.5 %) 46 (46.9 %)
TNM clinical stage 0.929c
I 29 (21 %) 28 (20.9 %) 9 (22.5 %) 20 (20.4 %)
II 43 (31.2 %) 41 (30.6 %) 12 (30 %) 31 (31.6 %)
III 45 (32.6 %) 44 (32.8 %) 14 (35 %) 31 (31.6 %)
IV 21 (15.2 %) 21 (15.7 %) 5 (12.5 %) 16 (16.4 %)
Tumour grade (n = 136a; n = 132b) 0.373c
Low grade 108a (79.4 %) 106b (80.3 %) 33 (82.5 %) 75 (76.5 %)
High grade 28a (20.6 %) 26b (19.7 %) 7 (17.5 %) 21 (21.4 %)
Lymph node status 0.388c
Yes 63 (45.6 %) 62 (46.3 %) 17 (42.5 %) 46 (46.9 %)
No 75 (54.4 %) 72 (53.7 %) 23 (57.5 %) 52 (53.1 %)
Distant metastases 0.389c
Yes 21 (15.2 %) 21 (15.7 %) 5 (12.5 %) 16 (16.3 %)
No 117 (84.8 %) 113 (84.3 %) 35 (87.5 %) 82 (83.7 %)
Blood vessel invasion 0.106c
Yes 24 (17.4 %) 23 (17.2 %) 10 (25 %) 14 (14.3 %)
No 114 (82.6 %) 111 (82.8 %) 30 (75 %) 84 (85.7 %)
Survival (n = 134)
5 years (median survival in months, 95 % CI,
N° deaths)
‐‐ 59 (95 % CI –; 69 deaths) – (14 deaths) 49 (95 % CI 32.9–65.1; 55
deaths)
0.083e
10 years (median survival in months, 95 % CI,
N° deaths)
‐‐ 59 (95 % CI 27.3–90.7; 80
deaths)
– (95 % CI –; 16
deaths)
49 (95 % CI 32.9–65.1; 64
deaths)
0.036e
Median follow-up; range (months) ‐‐ 169; 166.75–171.25; 86
deaths
n/a; 20 deaths n/a; 66 deaths 0.111e
Allred score (8-oxodG) n/a
0 40 (29 %) 37 (27.6 %) 40 (100 %) 0
3 6 (4.3 %) 6 (4.5 %) 0 6 (6.1 %)
4 13 (9.4 %) 13 (9.7 %) 0 13 (13.3 %)
5 13 (9.4 %) 13 (9.7 %) 0 13 (13.3 %)
6 24 (17.4 %) 24 (17.9 %) 0 24 (24.5 %)
7 22 (15.9 %) 22 (16.4 %) 0 22 (22.4 %)
8 20 (14.5 %) 19 (14.2 %) 0 20 (20.4 %)
Statistical tests were conducted between Allred positive and negative patients
aIn 5 year survival group 136 out of 138 patients had data about tumour grade
bIn long-term survival group 132 out of 134 patients had data about tumour grade
cPearson chi-square test for association
dIndependent t test procedure was used, including data which were normally distributed and met criteria of homogeneity variances
eLog-rank)
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Fig. 2 Flow diagram representing number of patients at each stage of the study
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Additionally, the results showed a positive correlation
between higher Allred score and high tumour grade
(two-tailed Spearman’s ρ, 184; p < 0.05) (Fig. 4). Also,
higher Allred score correlated positively with non-
polypoid tumour growth (two-tailed Spearman’s ρ, 198;
p < 0.05) (Fig. 5).
Survival analysis (n = 134) was adjusted for age, gender,
and tumour stage as confounders. Those confounders
were identified to significantly impact survival estimated
by Cox regression models as follows: age (p = 0.021; haz-
ard ratio (HR) 1.028; 95 % confidence interval (CI) range
1.004–1.052), gender (p < 0.0001; HR 0.422; 95 % CI range
0.263–0.679), and TNM stage (stage I p < 0.0001; HR not
applicable (n/a); 95 % CI range n/a; stage II p < 0.0001; HR
0.210; 95 % CI range 0.100–0.437; stage III p < 0.0001; HR
0.327; 95 % CI range 0.176–0.607; stage IV p = 0.024; HR
0.517; 95 % CI range 0.291–0.917). There was no differ-
ence in survival between the two groups of patients basedFig. 3 Kaplan–Meier curve, 15-year survival, starting at 100 % survival. Green li
cells and blue line represents patients without reaction. (5-year survival, n=138
Mantel–Cox, chi-square 4.374, df=1, p<0.05)upon Allred score negative versus positive status in
tumour tissue and normal mucosis (Table 2).
A positive correlation between the non-polypoid macro-
scopic appearance of tumours with a higher percentage of
8-oxodG positive tumour cells and higher intensity of reac-
tion as well as higher Allred score was found (n = 138, two-
tailed Spearman’s ρ 0.209; p < 0.05; ρ 0.189; p < 0.05;
ρ 0.198; p < 0.05, respectively). There was no significant
difference of 8-oxodG expression related to age, sex, blood
group, size and tumour site, distance from the edge of the
resected tumour margin, and lymph nodes involvement.
There was no statistically significant correlation between
the presence of 8-oxodG within the cytoplasm of tumour
cells and the presence of vascular invasion.
Discussion
8-oxodG as a marker of oxidative stress in cells can be
evaluated via two groups of methods for 8-oxodG detec-
tion. Quantitative methods include high-performancene represents patients with cytoplasmic reaction for 8-oxodG in tumour
, Mantel–Cox, chi-square 4.116, df=1, p<0.05; 10-year survival, n=134,
Fig. 4 Case distribution through Allred score by tumour grade, well/moderately differentiated representing low-grade CRC tumours, and poorly
differentiated representing high-grade tumours
Fig. 5 Case distribution through Allred score by macroscopic tumour appearance
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Table 2 Unadjusted and adjusted survival
p value HR 95 % CI range
Unadjusted
Allred score tumour tissue 0.116 0.669 0.405–1.104
Allred score normal mucosis 0.155 0.724 0.464–1.130
Adjusted
Allred score tumour tissue 0.291 0.759 0.454–1.267
Allred score normal mucosis 0.214 0.748 0.474–1.182
Two groups of patients based upon Allred score negative versus positive
status (both in tumour tissue and normal mucosis), assessed by unadjusted
Cox regression model and adjusted for age, gender, and clinical stage
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trometry, or enzyme-linked immunosorbent assay, while
immunohistochemistry represents a qualitative method
[12]. Qualitative methods allow morphological insight
into the degree of oxidative DNA damage. Because of
these characteristics, immunohistochemical detection
methods with 8-oxodG specific monoclonal antibody are
particularly suitable to assess the correlation between
the 8-oxodG presence in tumour cells and cells of adja-
cent normal mucosa in the patients with CRC.
The problem of research studying the relationship
between oxidative stress and carcinogenesis is the inability
of a clear differentiation between oxidative damage as theFig. 6 Kaplan–Meier curve, 15-year survival, Dukes A group, starting at 100
8-oxodG in tumour cells, blue line represents patients without reaction. Wo
group is suspected due to systematic influence of oxidative stresscause or consequence [9]. Damage caused by oxidative
stress present in a variety of chronic inflammatory condi-
tions, and chronic diseases had been linked to carcinogen-
esis in many studies [14–16]. Our results showed that the
group of patients who survive the first 5 years after surgery
had a significantly lower percentage of 8-oxodG-positive
tumour cells, lower intensity of the staining reactions, and
consequently lower values by Allred score. One has to have
in mind that the presented patients with CRC were at dif-
ferent stages of the disease during primary tumour resec-
tion, and their survival was influenced by a multitude of
factors, including the various forms of the applied adjuvant
oncological treatment, although none received neoadjuvant
chemoradiotherapy that could theoretically alter oxidative
status. Although there was no statistically significant dif-
ference in survival of the patients grouped by the local
stage disease compared to 8-oxodG, long-term survival
was better in the patients with early stage disease, such as
Dukes A stage, suggesting that systemic influence of oxi-
dative stress may predispose to worse prognosis (Fig. 6).
Survival did not differ significantly between the groups of
patients without reaction to 8-oxodG in tumour cells
compared to the group of patients in whom there was a
positive reaction to 8-oxodG. Ten-year survival confirmed
the worse prognosis of the patients with higher intensity
staining of 8-oxodG reaction, but a higher percentage of% survival. Green line represents patients with cytoplasmic reaction for
rse long-term survival of patients positive to 8-oxodG in early stage
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worse prognosis. The assumption is that patients with a
positive reaction have higher clearance from survival
pool, while influencing the survival curve in the long
term. The assumption upon results from previous
studies stated that the presence of 8-oxodG varied
with the progression of the disease, and in patients
with the development of distant metastases, stronger
presence of 8-oxodG was noted [17].
The lack of 8-oxodG presence within the cytoplasm of
tumour cells was associated with better overall outcome.
Earlier publications described worse survival if 8-oxodG
was present in renal cell carcinoma as well as in lung
adenocarcinomas and non-small cell cancers [18, 19]. On
the contrary, breast cancers immunohistochemically nega-
tive for 8-oxodG were associated with more aggressive
disease and worse survival [20]. The above result attracts
attention and requires further clarification. Earlier studies
explored 8-oxodG presence in the tumour cell cytoplasm
of patients without structural colon diseases and found no
significant associations with age [17]. Hypothesis suggested
that in patients without structural colon disease, cells with
high levels of nuclear 8-oxodG undergo apoptosis due to
detectable DNA damage, which is an indirect evidence of a
functional mechanism to prevent further accumulation of
mutations [17]. The patients who had failed the apoptosis
of cells with damaged DNA have residual mutant pheno-
type, which may contribute to the further accumulation of
mutations and the development of genetic instability [21].
A higher percentage of tumour cells with the reaction of 8-
oxodG and higher Allred scores correlated positively with a
less differentiated histological grade of the tumour. Based
on these data, the assumption is that greater exposure to
oxidative stress leads to the growth of cancers that are
poorly differentiated, this alone influence survival with a
worse prognosis [22].
Carcinogenesis of CRC favours adenomatous polyps as
premalignant lesions, but non-polypoid adenomas (that
include lesion slightly elevated above the mucosal lining
of the plane or below the epithelium) are responsible for
the formation of considerable number of CRCs. Accord-
ing to the data of Kudo et al. [23] on 14,014 adenomas
and early CRCs, proportion of non-polypoid lesions was
44.5 %, and lesions located below the epithelium were
present in 2.3 % of cases, but those were responsible for
the occurrence of cancer in 32.4 % of cases [23]. It ap-
pears that greater exposure to oxidative stress contrib-
utes to non-polypoid cancer development. Given the
relatively small sample size of this study, a definite con-
clusion could not be reached.
Vascular invasion is related to invasion of peritu-
moural vascular structures and is associated with poor
prognosis of patients with CRC. More often it is the
penetration through the wall of the vein responsible forthe vascular invasion in colorectal carcinoma [24]. The
assumption is that the pathogenesis of vascular invasion
in CRC depends more on the invasiveness of tumour
cells clones than to the exposure of tissues to oxidative
stress. Data of vascular invasion did not have a signifi-
cant impact on the results of this study.
Conclusions
According to the previous research on the subject of oxida-
tive stress and CRC and the results of this study, it seems
that a certain part of the mutations responsible for CRC
development may be attributable to the reactive chemical
compounds. If the 8-oxodG-influenced CG-TA mutation
results in the formation of CRC, these patients would have
a worse prognosis. In later follow-up, patients with positive
reaction to 8-oxodG are probably influenced more by gen-
eral health impairment due to oxidative stress rather than
the influence of oxidative stress on tumour carcinogenesis.
The study results confirmed a positive correlation between
level of 8-oxodG in tumour tissue of patients with CRC
and higher tumour stage but failed to confirm worse out-
come of such patients. The displayed results should be seen
as a guideline for the proper formation of future prospect-
ive studies with a larger sample size to reach relevant infor-
mation about oxidative stress influence on survival.
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